-
GENEL
Created in 2014
-
-
Trend leader (A+)
Existing signals make this entity one of the most dynamic startups -
Social networks
1,770 -
Activities
-
Entity types
-
Location
29 Bd des Alpes, 38246 Meylan Cedex, France
Meylan
France
-
Employees
Scale: 11-50
Estimated: 311
-
SIREN
803280122 -
Engaged catalyst
1
0 0 -
Added in Motherbase
7 months, 3 weeks ago
-
Value proposition
Elevating the health and beauty of life
GENEL is an international French biotech company that offers expert multi-disciplinary services to Dermo-Cosmetic, Nutraceutique and Pharmaceutical companies. We support our clients by identifying the right commercial strategy for the successful launch of their product.
GENEL for Cosmetics, Dermo and Nutraceutique:
Works hand in hand with you to build the unique story of each of your ingredients, and thus elevate the specialty and values of your brand.
Thanks to more than 10 years expertise in Skin Homeostasis and in Functional Genomics, we specialize in assisting companies like you that are in the Dermo- Cosmetic and/or Nutraceutical market in defining and implementing innovative processes to scientifically identify the unique story of your active ingredients or finished product.
With more than 30 projects launched and the co-construction with our clients of more than 7 scientific posters published in 2019. We invite you to make us part of your scientific teams, to accompany you in the validation of your scientific projects, as well as to help you in the co-creation of the content of your marketing communication, for a better positioning in the market.
Be part of the community of companies that like to innovate and offer better and healthier products on the market.
GENEL for Pharma :
Because we know the importance of your role in the R&D of treatments for cancer therapy. We accompany you in the development of these treatments thanks to new technologies based on a modern generation microscope, coupled with #deeplearning algorithms. Our goal is to enable you to promote access to more effective, less expensive treatments adapted to each patient's pathology.
Our strong expertise in tumor models allows us to offer you 3D organoid cultures of the most difficult cancers to study, such as prostates, breasts and pancreas.
We are present in Europe, North America and South America.
Phenotypic Screening for 2D&3D Cellular Models, RNAi Screening, Target Discovery, Gene Regulation, High Content Throughput, Active ingredient, and Cosmetic active ingredients -
Original language
Elevating the health and beauty of life
GENEL is an international French biotech company that offers expert multi-disciplinary services to Dermo-Cosmetic, Nutraceutique and Pharmaceutical companies. We support our clients by identifying the right commercial strategy for the successful launch of their product.
GENEL for Cosmetics, Dermo and Nutraceutique:
Works hand in hand with you to build the unique story of each of your ingredients, and thus elevate the specialty and values of your brand.
Thanks to more than 10 years expertise in Skin Homeostasis and in Functional Genomics, we specialize in assisting companies like you that are in the Dermo- Cosmetic and/or Nutraceutical market in defining and implementing innovative processes to scientifically identify the unique story of your active ingredients or finished product.
With more than 30 projects launched and the co-construction with our clients of more than 7 scientific posters published in 2019. We invite you to make us part of your scientific teams, to accompany you in the validation of your scientific projects, as well as to help you in the co-creation of the content of your marketing communication, for a better positioning in the market.
Be part of the community of companies that like to innovate and offer better and healthier products on the market.
GENEL for Pharma :
Because we know the importance of your role in the R&D of treatments for cancer therapy. We accompany you in the development of these treatments thanks to new technologies based on a modern generation microscope, coupled with #deeplearning algorithms. Our goal is to enable you to promote access to more effective, less expensive treatments adapted to each patient's pathology.
Our strong expertise in tumor models allows us to offer you 3D organoid cultures of the most difficult cancers to study, such as prostates, breasts and pancreas.
We are present in Europe, North America and South America.
-
Home - GENEL
https://genel.fr/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Tarmac incubator
Startup accelerator & VC, Non-profit Organizations (Auto) |
Tarmac incubator
Startup accelerator & VC, Non-profit Organizations (Auto) |
Other
31 Jan 2026 |
|
|